You are here

  • Home
  • Archive
  • Volume 68, Issue 10
  • The interleukin 1 inhibitor rilonacept in treatment of chronic gouty arthritis: results of a placebo-controlled, monosequence crossover, non-randomised, single-blind pilot study

Article info

Article menu
Clinical and epidemiological research
Concise report
The interleukin 1 inhibitor rilonacept in treatment of chronic gouty arthritis: results of a placebo-controlled, monosequence crossover, non-randomised, single-blind pilot study

Authors

  1. Correspondence to Dr R Terkeltaub, VAMC Rheumatology, 111K, 3350 La Jolla Village Drive, San Diego, CA 92161; rterkeltaub@ucsd.edu
View Full Text

Citation

Terkeltaub R, Sundy JS, Schumacher HR, et al
The interleukin 1 inhibitor rilonacept in treatment of chronic gouty arthritis: results of a placebo-controlled, monosequence crossover, non-randomised, single-blind pilot study
Annals of the Rheumatic Diseases 2009;68:1613-1617.

Publication history

  • Accepted June 26, 2009
  • First published July 26, 2009.
Online issue publication 
October 25, 2017

Copyright information

© Terkeltaub et al 2009 This is an open-access article distributed under the terms of the Creative Commons Attribution Non-commercial License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.